- Home
- VFS vs LEGN Comparison
VFS vs LEGN Comparison
Compare VFS & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VFS | LEGN |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | Vietnam | United States |
| Employees | 17823 | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.9B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | VFS | LEGN |
|---|---|---|
| Price | $4.29 | $28.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | $5.83 | ★ $61.33 |
| AVG Volume (30 Days) | 926.8K | ★ 2.7M |
| Earning Date | 06-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $70.58 | $42.68 |
| Revenue Next Year | N/A | $30.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.78 | $16.24 |
| 52 Week High | $5.29 | $45.30 |
Technical Indicators
Market Signals| Indicator | VFS | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 56.52 | 74.99 |
| Support Level | $3.16 | $21.27 |
| Resistance Level | $4.88 | $28.97 |
| Average True Range (ATR) | 0.25 | 1.89 |
| MACD | -0.05 | 0.50 |
| Stochastic Oscillator | 20.62 | 79.19 |
Price Performance
Historical ComparisonAbout VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.